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ABSTRACT  
Objective: There is a growing interest in traditional medicinal plants since they contain medicinally active products to remedy many diseases. 
Punica granatum (PG) has many medicinal applications. The aim of this study was to investigate the antidiabetic, hypolipidemic, antioxidant and 
hepato-pancreatic protective effects of PG peel powder (PGPP) on streptozotocin (STZ) induced diabetic rats.  
Methods: Male Swiss albino rats became diabetic with insulin-dependent diabetes mellitus (IDDM) after a single intravenous injection of STZ (50 mg/kg). 
IDDM-rats received either a daily oral dose of PGPP (200 mg/kg), or insulin for 20 days. On day 21, rats were sacrificed and levels of fasting blood glucose 
(FBG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, lipid profile, lipid peroxidation (LPO), nitric oxide (NO), superoxide 
dismutase (SOD), and total antioxidant capacity (TAC) were estimated. Histopathological studies of liver and pancreas were performed.  
Results: There was a significant elevation in FBG, AST, ALT activities, NO and LPO levels for induced IDDM. In contrast, albumin level, SOD activity, 
and TAC exhibited the significant decline. In addition, there was marked lipid profile disturbances, and histopathological changes of liver and 
pancreas. Following PGPP supplementation, the levels of all the above-mentioned factors were back to normal. Also, liver architecture and the size 
of an islets of Langerhans of the pancreas were almost back to normal. The effect of PGPP was more pronounced when compared with insulin.  
Conclusion: PGPP is an effective alternative for the treatment of IDDM through the regeneration of β cells of pancreas and via its strong antioxidant 
properties. 
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INTRODUCTION 
Diabetes mellitus (DM) is considered as the most common endocrine 
disease and heterogeneous metabolic disorder; affecting 5% of the 
world’s population. It is characterized by insufficiency of insulin 
secretion and/or action, insulin resistance, and abnormal 
metabolism of glucose, lipid and protein. Globally, DM causes high 
mortality and is the second most common cause of death after 
cancer. It is known to cause a variety of complications such as renal 
failure, blindness, limb amputation, neurological complications, 
vascular complications of coronary artery disease, cerebrovascular 
disease and/or premature death [1, 2]. DM is categorized into 
several types the two major ones are type 1 and type 2. On the basis 
of etiology, the term type 1 and type 2 are widely used to describe 
insulin-dependent diabetes mellitus (IDDM) and noninsulin-
dependent diabetes mellitus (NIDDM), respectively [3]. Although 
different types of oral hypoglycemic agents are available along with 
insulin for the treatment of DM, none offers complete glycemic 
control [2]. In addition, the side effects of taking insulin and oral 
hypoglycemic agents have brought about a growing interest among 
those patients for alternative traditional medicinal plants with 
antidiabetic activity [4]. Therefore, an investigation of such agents 
has become of great interest. 
The pomegranate, botanical name Punica granatum (P. granatum) is 
a fruit-bearing deciduous shrub or a small sized tree that belongs to 
the Punicaceae family [5]. Nowadays, it is widely cultivated 
throughout the Middle East, Northern and Tropical Africa, Central 
Asia, and drier parts of Southeast Asia [6]. Pomegranates may 
contain nearly three times antioxidants as green Tea [5]. Compared 
with the pulp, the inedible Punica granatum (PG) peel contains as 
much as three times the total amount of polyphenols, including 
condensed tannins and catechins, gallocatechins and 
prodelphinidins [7, 8]. The antioxidant capacity of PG peel extract is 
10 times higher than the pulp extract [9].  
PG has been used for thousands of years to cure a wide range of 
diseases across different cultures and civilizations. It has been used in 
natural and holistic medicine to treat sore throats, coughs, urinary 
infections, digestive disorders, skin disorders, arthritis, and to expel 
tapeworms. However, modern research suggests that it might be 
useful for the treatment of serious conditions as prostate cancer, skin 
cancer, osteoarthritis, and diabetes. Studies also show that 
pomegranate seeds might help clear the digestive system from fats. 
Clinical research suggested that PG has the potential to thin the blood, 
increase blood flow to the heart, reduce blood pressure, reduce plaque 
in the arteries, and reduce bad cholesterol while increasing good one. 
A decoction of seed is used to treat syphilis while the juice is used to 
treat jaundice and diarrhea. The flower juice is used to treat nose 
bleeding. The fruit pulp and the seed are stomachic. Dried, pulverized 
flower buds are employed as a remedy for bronchitis [10].  
Moreover, many studies have shown that PG peel extract has radio-
protective, antifibrotic and wound healing properties. In addition, it 
possesses antioxidant, immunomodulatory, antibacterial, 
gastroprotectective, larvicidal, antifungal, antitumor, antimicrobial, 
antiviral and hypoglycemic activities [11, 12]. Also, PG has a 
protective role against fatty liver in obesity through improvement of 
abnormal lipid metabolism. On the other hand, the inhibition of 
carbohydrate digestive enzymes and its phenolic content may 
contribute to the antihyperglycemic effects of PG flower and peel, 
and support their claims in diabetes. Other studies indicated that the 
methanolic extract of PG peel has beneficial influences over the 
inhibition of induced oxidative stress and histopathological 
alternations in liver and kidney of female rats, and these effects may 
be related to antiapoptotic and antioxidant activities [12]. Recent 
research has focused on the potential effect of PG for the treatment 
of cardiovascular disease, diabetes, and various forms of cancer [10].  
This research was designed to study the effect of streptozotocin 
(STZ) induced IDDM on food and drink habits, liver function and on 
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the antioxidant/lipid status. In addition to investigate the possibility 
of the PG peel powder (PGPP) supplementation to ameliorate the 
damaged tissue of liver and pancreas caused by hyperglycemia 
induced oxidative stress in experimental diabetes. 
MATERIALS AND METHODS 
Drugs, chemicals and kits 
Zinc-insulin suspension (Lente insulin) [Monotard, Novo Nordisk, 
Bagsvaerd, Denmark ] , Streptozotocin [N-(Methyl nitroso 
carbamoyl)-α-D-glucosamine], STZ (Sigma, St. Louis, MO, USA), 
aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT) kits [ELITech clinical systems, France], albumin kit [STANBIO 
Company, USA], total cholesterol, high density lipoprotein (HDL) and 
triglycerides (TG) Kits [SPINREACT, Santa Coloma, Sant Esteve De 
Bas, Spain], and malondialdehyde (MAD), superoxide dismutase 
(SOD), nitric oxide (NO) and total antioxidant capacity (TAC) kits 
[Biodiagnostic Company, Cairo, Egypt] were used. Other chemicals 
used throughout this investigation were of the highest analytical 
grade available. 
Plant material 
Fresh PG fruits were purchased from local markets, Egypt. Fruits 
were cut into portions and arils were separated manually from 
peels. The peels were cut into small pieces and sun dried until 
complete dehydration. Dried peels were grounded into fine powder 
in a mortar. Peels powder was kept in an airtight plastic container 
and stored at 5 ˚C until used. Peels powder was suspended in warm 
distilled water (100 mg/1 ml) and was given orally through the 
stomach tube to rats at a dose of 200 mg/kg.  
Maintenance of animals 
Adult male Swiss albino rats weighing (120-160 g) purchased from 
Urology and Nerphology Centre, Mansoura University, Egypt were 
used. All animals were housed for about 10 days before used in 
experiments under standard conditions (temperature of 25 ˚C, relative 
humidity and a 12/12 h light/dark cycle) according to the criteria 
outlined in the ‘‘Guide for the Care and Use of Laboratory Animals’’ 
prepared by the National Academy of Sciences and published by the 
National Institute of Health [13]. Food and water ad libitum were 
allowed. This was approved by the Animal House of Biochemistry, 
Chemistry Department, Faculty of Science, Damietta University, Egypt.  
Induction of insulin-dependent diabetes mellitus (IDDM)  
The rats fasted for 12 h and IDDM were induced by a single 
intravenous injection of freshly prepared STZ at a dose of 50 mg/kg 
[3]. STZ was dissolved in ice-cold 0.1 M sodium citrate buffer, pH 4.5 
[14]. Normal control rats received an equivalent amount of buffer 
intravenously. Rats were allowed to drink 5% glucose solution 
overnight to overcome drug-induced hypoglycemia. Diabetes was 
confirmed after 48 h of STZ administration by measuring fasting 
blood glucose concentration from the tail vein, using commercial 
glucose strips and a glucometer from Boehring-Mannheim 
Diagnostica, Mannheim, Germany [15]. Only rats with fasting blood 
glucose level of 250 mg/dl and above were considered diabetic and 
used for the experiment. The day on which diabetes had been 
confirmed was designated as day zero.  
Experimental design 
Animals were divided into 4 groups (seven rats/group) as follows: 
normal control group; diabetic control group involved rats received 
a single dose of STZ (50 mg/kg, I. V.); diabetic+insulin group 
involved STZ induced diabetic rats (50 mg/kg, I. V.) treated with the 
standard drug insulin (6 IU/kg, S. C.) once every 48 h for 20 days 
[16]; and diabetic+PG group involved STZ induced diabetic rats (50 
mg/kg, I. V.) treated with a daily oral dose of PGPP (200 mg/kg) 
through the stomach tube for 20 days.  
The food and water intake of all groups were recorded daily while 
body weight and fasting blood glucose level were determined 
weekly throughout the experimental period.  
Samples 
On the 21st day, all animals fasted for 12 h then sacrificed under 
diethyl ether anesthesia and blood samples were collected via the 
retro-orbital venous plexus. Blood samples were left to clot and the 
sera were separated by centrifugation at 4 ˚C, 3000 rpm for 10 min 
and stored at-20 until used for the biochemical estimations. All 
measurements of the biochemical parameters were carried out 
according to the kits instructions. 
Histopathological analysis 
Liver and pancreas obtained after decapitation were washed in 
saline and fixed in 10% formalin for the routine haematoxylin and 
eosin (H&E) staining technique and histopathological examinations. 
Fixed tissues were processed routinely, embedded in paraffin wax, 
sectioned into 5 µm thick sections in a rotary microtome and then 
stained with H&E dye. At least three different sections per sample 
were examined. The pathologist evaluating liver and pancreas 
sections was unaware of the treatment the rat had received. 
Statistical analysis 
Results are presented as mean±SD A statistical analysis between two 
groups were performed using Student's t-test. P<0.05 was 
considered significant for all analysis. An IBM computer with a 
statistical software system instate version 3.10 (Graphpad, USA) was 
used for these calculations. 
RESULTS 
Water and food intake 
The volume of water intake in diabetic control group was 
significantly (P<0.001) higher than that in normal control group and 
increased progressively till the end of the experiment. In diabetic 
rats supplemented with PGPP, a significant (P<0.01 vs. diabetic 
control) decrease in daily water intake was observed from day 5 of 
treatment and that decrease was persistent. In the case of insulin 
supplementation a significant decrease (P<0.001 vs. diabetic 
control) was observed from day ten however the values were still 
higher than those of the prior to the induction of diabetes (table 1). 
 
Table 1: Water intake (ml) in rats groups 
Groups Normal control Diabetic control  Diabetic+Insulin Diabetic+PG 
5 PthP day 123±3.109 211±2.709P$$$ 201±10.033 194.7±4.646** 
10 PthP day 120±4.349 276.5±5.066P$$$ 192.25±2.217*** 182.5±2.082*** 
15 PthP day 122.2±1.708 282.25±2.217P$$$ 184.5±4.203*** 165±1.633*** 
20 PthP day 122.2±2.217 284.7±1.258P$$$ 164±0.8165*** 153±2.160*** 
PG; Punica granatum . Data are expressed as mean±SD (n = 7 rats in each group), $$$: P< 0.001 versus normal control group. ** and ***: P < 0.01 and 
P < 0.001, respectively versus diabetic control group. 
 
Table 2: Food intake (g) in rats groups 
Groups Normal control Diabetic control  Diabetic+Insulin Diabetic+PG 
5 PthP day 300.25±2.449 262±2.449P$$$ 259.25±3.304 242±2.449*** 
10 PthP day 305.5±3.697 242±2.082P$$$ 267.25±2.630*** 257±1.862*** 
15 PthP day 314.25±4.349 235±3.559P$$$ 268.25±4.573*** 264.25±3.775*** 
20 PthP day 323±2.160 221.5±3.109P$$$ 272.25±3.559*** 272±3.559*** 
PG; Punica granatum . Data are expressed as mean±SD (n = 7 rats in each group), $$$: P < 0.001 versus normal control group. ***: P < 0.001 versus 
diabetic control group. 
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In table 2, food intake was significantly decreased (P<0.001) in 
diabetic group from day five and proceeded till the end of the 
experiment whereas it was significantly (P<0.001) and continuously 
increased in the treated rats with either insulin or PGPP from day 15 
compared with diabetic rats.  
Body weight 
There was a significant reduction in body weight of the animals in the 
diabetic group with comparison to control. After supplementation 
with PG peels powder for 14 days, the body weight was notably 
regained. After 21 days of the supplementation, the animals started to 
gain their normal weight. With insulin treatment for 21 days, diabetic 
rats began to regain weight to a lesser extent (fig. 1).  
 
 
Fig. 1: Changes in rats' body weight (g) in all studied groups 
throughout the experimental period. Each bar represents the 
mean±SD of seven rats. PG; Punica granatum 
 
Fasting blood glucose level 
In the PG peels powder treated rats, hypoglycemic effect was evident 
from day seven onwards; the decrease in blood glucose level was 
highly pronounced on the day 21. The hypoglycemic effect of PG 
peels powder at 200 mg/kg dose was more prominent than insulin 
(the reference drug) (fig. 2). 
Liver function tests 
As indicated in table 3, serum AST and ALT activities were 
significantly (P<0.001) inhibited while the serum albumin level was 
highly increased (P<0.001) by insulin or PGPP supplementation 
when compared with those of the diabetic control group. The 




Fig. 2: Effects of treatment with Punica granatum (PG) peels 
powder on fasting blood glucose level (mg/dl) in streptozotocin-
induced diabetic rats. Each bar represents the mean±SD of seven 
rats. * Significant difference at P<0.001 level compared with the 
normal control group. ! Significant difference at P<0.001 level 
compared with the diabetic control group  
 
Biochemical parameters  
Lipid profile 
Significant decreases (P<0.001) in serum levels of cholesterol, low 
density lipoprotein (LDL), triglycerides accompanied with 
significant (P<0.001) elevation in serum HDL level were noticed in 
diabetic rats treated with insulin or with PGPP compared to those of 
untreated diabetic rats however, the hypolipidemic effect of PGPP 
was more superior than that of insulin (table 3).  
Lipid peroxidation and antioxidants 
Table 3 shows a significant (P<0.001) increase, to more than six 
folds, in serum lipid peroxidation marker (MDA) and a significant 
(P<0.001) elevation in NO level along with a significant (P<0.001) 
decrease in antioxidant defense markers (TAC and SOD) in control 
diabetic group compared with those of normal control group. Daily 
administration of PGPP reversed significantly (P<0.001) all these 
markers values towards normal and its effect was more superior to 
the reference drug. 
 
Table 3: Biochemical parameters of rats groups 
Groups Normal control Diabetic control Diabetic+Insulin Diabetic+PG 
ALT (IU/l) 66.27±5.359 104.67±13.910P*** 77.8±9.206P$$$ 73.93±5.133P$$$ 
AST (IU/l) 89.81±3.173 144.71±8.767P*** 102.01±6.473P$$$,** 90.75±2.712P$$$ 
Albumin (g/dl) 1.853±0.095 1.126±0.06P*** 1.545±0.06P$$$,*** 1.57±0.098P$$$,*** 
TG (mg/dl) 46.68±9.503 81.59±6.823P*** 56.97±6.758P$$$,* 55.77±2. 298P$$$ 
Cholesterol (mg/dl) 50.41±2.866 74.38±7.86P*** 65.82±2.524P$$,*** 55.74±3.523P$$$ 
HDL (mg/dl) 25.96±3.045 10.50±2.166P*** 25.77±2.279P$$$ 21.99±1.287P$$$ 
LDL (mg/dl) 15.08±2.440 47.16±8.930P*** 29.1±3.645P$$$,*** 22.5±5.590P$$$,* 
MDA (nmol/l) 1.47±0.093 9.84±1.207P*** 6.26±1.080P$$$,*** 4.48±1.139P$$$,*** 
TAC (mM/l) 1.631±0.057 0. 604±0.175P*** 1.58±0.054P$$$,* 1.404±0.0644P$$$ 
NO (mM/l) 0.015±0.006 0.042±0.003P*** 0.022±0.002P$$$,*** 0.017±0.0008P$$$ 
SOD (U/ml) 283.5±4.517 50.06±3.588P*** 170.3±12.105P$$$,*** 182.8±11.684P$$$,*** 
PG; Punica granatum, ALT; alanine transaminase, AST; aspartate transaminase, TG; triglycerides, HDL; high density lipoprotein, LDL; low density 
lipoprotein, MDA; malondialdehyde, TAC; total antioxidant capacity, NO; nitric oxide, SOD; superoxide dismutase. Data are expressed as mean±SD (n 
= 7 rats in each group), *, ** and ***: P < 0.05, P < 0.01 and P < 0.001, respectively versus normal control group. $$ and $$$: P < 0.01 and P < 0.001, 
respectively versus diabetic control group. 
 
Histopathological analysis 
As reflected from fig. 3, liver of diabetic rat showed histopathological 
changes including increase vacuolation in the cytoplasm of 
hepatocytes appeared as indistinct clear vacuoles indicating 
glycogen infiltration in diabetes. On the other hand, liver section of 
diabetic rat administered with insulin showed normal hepatocytes 
and normal hepatic architecture with mild vacuolation of 
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hepatocytes and liver section of diabetic rat administered with PGPP 
showed normal liver architecture with normal hepatocytes arranged 
in normal sheets or cord around central vein. 
As illustrated in fig. 4, the diabetic control rat pancreas has shrunken 
islets of Langerhans with degeneration and necrosis of cell 
components where its nucleus has a dense basophilic and karyolysis 
is evident. On the contrary, pancreas of diabetic rat treated with 
insulin showed normal islets of Langerhans with normal pale large 
round to ovoid shaped containing cells that embedded in exocrine 
portion of pancreas. In addition, pancreas of diabetic rat treated 
with PGPP showed normal size islets of Langerhans but some 
degeneration of the β cell in the center were noticed. 
 
 
Fig. 3: Liver histopathology. (A) Normal control rat liver showing 
normal hepatocytes (arrow) with normal radial arrangements 
around hepatic cords (H&E, x400). (B) Diabetic control rat liver 
showing increase vacuolation in the cytoplasm of hepatocytes 
appeared as indistinct clear vacuoles (arrows) indicate glycogen 
infiltration in diabetes (H&E, x400). (C) Liver of diabetic rat 
treated with insulin is showing normal hepatocytes and normal 
hepatic architecture with mild vacuolation of hepatocytes 
(arrow) (H&E, x100). (D) Liver of diabetic rat treated with Punica 
granatum peels powder showing normal liver architecture with 
normal hepatocytes arranged in normal sheets or cord around 
central vein (H&E, x400) 
 
DISCUSSION 
Hypoglycemic drugs are either too expensive or have undesirable 
side effects including hematological, coma and disturbances of liver 
and kidney. Controlling diabetes without any side effects is still a 
challenge for the medical system. This leads to exert effort to search 
for effective, safer and less cost antidiabetic traditional plants [11]. 
In addition to its ancient historical uses, PG is used in several 
systems of medicine for a variety of diseases. It is used as an 
antiparasitic agent, a “blood tonic” and to heal aphthae, diarrhea, 
and ulcers. It also serves as a remedy for diabetes [17]. In the 
present study, the antidiabetic, hypolipidemic, antioxidant and 
hepato-pancreatic protective effects of PGPP, were tested on STZ 
induced diabetic rats. During treatment of diabetic rats with PGPP, 
rats daily water intake decreased from the day 5 of treatment and 
continued to go down and the animals food intake increased 
continuously from day 15 of treatment and this generated a 
difference in the body weight between treated and untreated rats. 
The body weight of treated rats reached its normal maximum 
individual value of 182 g by the end of the third week of the 
experiment. These improvements might be related to the enhanced 
relaxation in diabetic rats owing to the decrease in blood sugar as a 
result of treatment with PGPP all over the treatment period. This 
suggests that, PGPP administration can minimize IDDM symptoms. 
 
Fig. 4: Pancreas histopathology. (A) Normal control rat pancreas 
showing normal islets of Langerhans with pale rounded and 
ovoid β-cells in the center (arrow), embedded in exocrine portion 
of pancreas (H&E, x400). (B) Diabetic control rat pancreas 
showing shrinkage of islets of Langerhans with degeneration and 
necrosis of components cells where its nucleus appeared densely 
basophilic and karyolysis is evident (arrow) (H&E, x400). (C) 
Pancreas of diabetic rat treated with insulin showing normal 
islets of Langerhans with its normal pale large round to ovoid 
shaped containing cells (arrow) that embedded in exocrine 
portion of pancreas (H&E, x400). (D) Pancreas of diabetic rat 
treated with Punica granatum peels powder showing normal 
sized islets of Langerhans but some degeneration of the β cell in 
the center were noticed (arrow) (H&E, x400) 
 
As shown in fig. 2, PGPP hypoglycemic effect at 200 mg/kg dose on 
diabetic rats is more prominent than insulin; it is evident from the 
day seven and it is highly pronounced on the day 21, this is may be 
attributed to its inhibitory action on intestinal absorption of glucose. 
This is in accordance with [18] and [19]. In addition, PGPP treatment 
restored and regenerated pancreatic β cells and showed normal 
sized islets of Langerhans (fig. 4). This indicates that PG peels have 
protective effects on rat pancreas and adds extra evidence for its 
antidiabetic properties. Banihani et al. [20] in their review reported 
that fasting blood glucose levels were decreased significantly by 
punicic acid, methanolic seed extract, and pomegranate peel extract. 
They used bioactive compounds already in PG such as punicalagin, 
ellagic, gallic, oleanolic, ursolic, and uallic acids which have been 
identified to have antidiabetic actions. These findings provide 
another evidence for the antidiabetic activity of PG fruit. It was 
reported for both in vivo and in vitro studies that PG exerts 
hypoglycaemic effects, including increased insulin sensitivity, 
inhibition of α-glucosidase, and has an impact on glucose 
transporter type 4 function [21].  
Oxidative stress can be defined as the imbalance between oxidants 
and antioxidants in favor of the oxidants, potentially leading to 
cellular damage. Free radicals are reactive oxygen species having an 
unpaired electron, which are generated under physiological 
conditions during aerobic metabolism. These free radicals have the 
potential to trigger chain reactions when they react with proteins, 
lipids and other biological molecules, which are fatal to the cell. 
Under normal conditions, the free radicals that are produced are 
scavenged by a repertoire of enzymatic antioxidants like SOD, 
catalase, etc. and also by non-enzymatic antioxidants like vitamin C, 
alpha-tocopherol, glutathione, etc., thus preventing the oxidative 
stress [22]. The previous studies have demonstrated that the 
development of diabetic complications in diabetes is closely related 
to the increased generation of superoxide anion and NO [23]. 
Decreased activities of antioxidant enzymes, SOD, in the kidney of 
STZ-induced diabetic rats have been reported [24]. Although, in 
another study, total antioxidant activity was reported to be 
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exceeding the normal values in plasma and saliva of diabetic 
patients suggesting existence of increased free radical production 
[25]. However, there are also studies showing no significant 
difference in antioxidant status between patients and healthy 
controls [26].  
The current investigation demonstrates that PGPP possesses strong 
antioxidant properties; can act as a free radical scavenger and protects 
different vital organs especially liver and pancreas from damage in 
diabetic rats. Its antioxidant action can be indicated from table 3, 
which shows the ability of PG peels to increase the TAC and SOD and 
to decrease MDA and NO in treated diabetic rats. Antioxidants counter 
the action of free radicals by several mechanisms. These mechanisms 
include: (1) enzymes that degrade free radicals, (2) proteins such as 
transferrin that can bind metals which stimulate the production of free 
radicals, and (3) antioxidants such as vitamins C and E that act as free 
radical scavengers [27]. One key mechanism by which PG fractions 
affect diabetes is by reducing oxidative stress and lipid peroxidation. 
This reduction may occur by directly neutralizing the generated 
reactive oxygen species, increasing certain antioxidant enzyme 
activities, inducing metal chelation activity, reducing resist in 
formation, and inhibiting or activating certain transcriptional factors, 
such as nuclear factor kappa B and peroxisome proliferator-activated 
receptor γ [20].  
In harmony with many previous studies [28-32], our present results 
in table 3 show a significant decrease in ALT and AST and a 
significant increase in serum albumin in diabetic rats treated with 
PGPP when compared with control diabetic group. Additionally, fig. 
3 shows normal liver architecture with normal hepatocytes of 
diabetic rats administered PGPP. Moreover, diabetic rats developed 
a significant lowering in serum HDL level and significant elevation in 
levels of serum total cholesterol, triglycerides and LDL. After 
treatment with PGPP there were significant decreases in serum total 
cholesterol, triglycerides, and LDL levels and a significant increase in 
HDL level. These results demonstrate that PG peels have 
hepatoprotective and hypolipidemic actions. This may be attributed 
to its strong antioxidant properties. Medjakovic and Jungbauer [21] 
stated that P. granatum not only exerts hypoglycaemic effects but 
also it is responsible for a reduction of total cholesterol, and the 
improvement of blood lipid profiles. Toklu et al. [33] studied the 
effect of chronic administration of PG peel extract on liver fibrosis 
induced by bile duct ligation. They showed that the elevated levels of 
AST and ALT were significantly decreased after treatment. Thus 
chronic pomegranate peel extract treatment, with its antioxidant 
and anti fibrotic properties may be of potential therapeutic value in 
protecting the liver from fibrosis and oxidative injury.  
CONCLUSION 
In conclusion, the present study showed that diabetic rats suffered 
from more oxidative stress. Oxidative stress plays a significant role 
in diabetes and its complications. This fact is to be kept in mind 
when planning strategies for the treatment of DM and prevention of 
its complications for better quality. PGPP has curative potentials as 
antidiabetic and antihyperlipidemic and hepato-pancreatic 
protective. This is possibly through having a role in regeneration of 
pancreatic β cells and via its strong antioxidant activity, which can 
fade oxidative stress. Therefore, PG peel and its active constituents 
are worthy of further investigations as safe and effective for medical 
treatments for IDDM and its pathological consequences. Large 
quantities of PG peel could be easily collected from PG processing 
industries or from the waste products originating, PG peel can 
provide an extra income. Based on our results, PG peel may also 
contribute to the nutritional values of PG fruit.  
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